Category: Biotech
Scientists Are One Step Closer to Treating Melanom...
Posted by Abigale Lormen | Sep 7, 2019 | Biotech | 0
NY Attorney General Probes Eli Lilly Over High Ins...
Posted by Abigale Lormen | Aug 3, 2019 | Biotech | 0
Gilead Beat Street Forecasts Due to Increasing Dem...
Posted by Abigale Lormen | Aug 1, 2019 | Biotech | 0
Cognetivity Neurosciences’ CMO to Present at...
Posted by Editorial Staff | Jul 16, 2019 | Biotech, Markets, Tech | 0
Early Detection of Dementia by Observing the Eyes
Posted by Abigale Lormen | Jul 11, 2019 | Biotech | 0
‘Blockbuster’ Migraine Therapy: Incentive for Lundbeck’s $2B Alder Acquisition
by Abigale Lormen | Sep 22, 2019 | Biotech | 0
Denmark’s international pharmaceutical company, Lundbeck has acquired Alder in a bid to...
Read MoreScientists Are One Step Closer to Treating Melanoma
by Abigale Lormen | Sep 7, 2019 | Biotech | 0
Last Sunday, researchers from the Massachusetts Institute of Technology presented their study...
Read MoreNY Attorney General Probes Eli Lilly Over High Insulin Prices
by Abigale Lormen | Aug 3, 2019 | Biotech | 0
Eli Lilly has been served a subpoena from the Office of the Attorney General in New York because...
Read MoreGilead Beat Street Forecasts Due to Increasing Demand for HIV Drug
by Abigale Lormen | Aug 1, 2019 | Biotech | 0
Gilead Sciences Inc. (GILD.O) beat Wall Street forecasts for its profit and revenue for the second...
Read MoreCognetivity Neurosciences’ CMO to Present at Alzheimer’s Association International Conference (AAIC) 2019
by Editorial Staff | Jul 16, 2019 | Biotech, Markets, Tech | 0
AAIC is the Largest and Most Influential International Meeting Dedicated to Advancing Dementia...
Read MoreEarly Detection of Dementia by Observing the Eyes
by Abigale Lormen | Jul 11, 2019 | Biotech | 0
Currently, many people around the globe develop dementia as they grow older. For the longest time,...
Read MoreMicrosoft Prepares to Make Biggest Gamble of 2019
by Abigale Lormen | Jul 10, 2019 | Biotech | 0
Microfost’s initial plans to invest in health-care company Adaptive Biotechnologies two...
Read MoreBitcoin is Back
by Abigale Lormen | Jun 24, 2019 | Biotech | 0
Facebook’s engagement in cryptocurrency is starting to bring Bitcoin back to mainstream investors’...
Read MoreAffordable Egg Freezing Solutions for Women Who Choose to Delay Parenthood
by Abigale Lormen | May 25, 2019 | Biotech | 0
Demand for a cost-effective egg freezing service rise as more and more millennial women reach...
Read MoreCognetivity Appoints Digital Health Specialist to Drive Platform Commercialization Strategy & Sales
by Abigale Lormen | May 2, 2019 | Biotech, Markets, Tech | 0
VANCOUVER, May 2, 2019 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”)...
Read MoreBiogen Repurchases $5 Billion Worth of Shares
by Abigale Lormen | Apr 1, 2019 | Biotech, Finance | 0
Last Monday, Biogen Inc. expressed their plans on buying back their shares of $5 billion. This is...
Read MoreCognetivity Neurosciences Selected to Present New Landmark Research Data
by Abigale Lormen | Mar 27, 2019 | Biotech, Markets, Tech | 0
Cognetivity Neurosciences Selected to Present New Landmark Research Data at the 14th International...
Read More
Recent Posts
-
Versus Systems Files to List on NasdaqNov 22, 2020 | Press Release
-
-
-
-
Golden Independence Engages Permitting ConsultantsNov 12, 2020 | Press Release